SCHEMBL10440646

SCHEMBL10440646

CCc1c(F)c(Cl)nc(Cl)c1C(=O)/C(=C\NC1CC1)C(=O)O

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10440647 1.00 POLB (0.30) POLB
SCHEMBL5775555 0.76
SCHEMBL5775558 0.76
SCHEMBL5775563 0.76
SCHEMBL9085693 0.76 NPSR1 (0.34) POLB
SCHEMBL9085697 0.76 NPSR1 (0.34) POLB
SCHEMBL10508912 0.74 CES2 (0.32)
SCHEMBL10508908 0.74 CES2 (0.32)
SCHEMBL5779089 0.71 KEAP1 (0.49)
SCHEMBL5779087 0.71 KEAP1 (0.49)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0387802-A2 5-Substituted-1,4-dihydro-4-oxonaphthyridine-3-carboxylate antibacterial agents Bristol-Myers Squibb Company (US) 1990-09-19 EP disclosed